How effective is taxane* containing chemotherapy for women with operable early breast cancer?
The review did not identify a subgroup of patients where taxane containing treatment may have been more or less effective. Dosage and scheduling of the taxanes used were not clearly defined so determining the optimal use of taxanes must await the next generation of studies.
Breast cancer is the commonest cancer in women (23% of all cancers), with an estimated 1.15 million new cases and over 411,000 deaths reported worldwide in 2002. Taxanes can inhibit cancer cells dividing and reproducing. Possible associated adverse effects include nausea, vomiting and increased risk of infections.